Mustang Bio Inc (MBIO)
0.2283
-0.01
(-3.14%)
USD |
NASDAQ |
Nov 15, 16:00
0.212
-0.02
(-7.14%)
After-Hours: 20:00
Mustang Bio Cash and Short Term Investments (Quarterly): 3.525M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.525M |
June 30, 2024 | 4.268M |
March 31, 2024 | 1.337M |
December 31, 2023 | 6.234M |
September 30, 2023 | 9.562M |
June 30, 2023 | 15.38M |
March 31, 2023 | 58.10M |
December 31, 2022 | 75.66M |
September 30, 2022 | 91.36M |
June 30, 2022 | 107.37M |
March 31, 2022 | 122.22M |
December 31, 2021 | 109.62M |
September 30, 2021 | 120.88M |
June 30, 2021 | 129.92M |
March 31, 2021 | 129.37M |
December 31, 2020 | 97.80M |
September 30, 2020 | 75.25M |
Date | Value |
---|---|
June 30, 2020 | 85.36M |
March 31, 2020 | 55.81M |
December 31, 2019 | 61.41M |
September 30, 2019 | 72.79M |
June 30, 2019 | 82.63M |
March 31, 2019 | 40.64M |
December 31, 2018 | 34.07M |
September 30, 2018 | 40.83M |
June 30, 2018 | 46.74M |
March 31, 2018 | 54.76M |
December 31, 2017 | 60.98M |
September 30, 2017 | 67.30M |
June 30, 2017 | 73.83M |
March 31, 2017 | 75.01M |
December 31, 2016 | 27.50M |
September 30, 2016 | 11.12M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.337M
Minimum
Mar 2024
129.92M
Maximum
Jun 2021
68.02M
Average
75.45M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Fortress Biotech Inc | 76.20M |
AIM ImmunoTech Inc | 10.06M |
Perspective Therapeutics Inc | 292.87M |
Protalix BioTherapeutics Inc | 45.03M |
Armata Pharmaceuticals Inc | 26.40M |